Companies Sued For Ozempic or Other GLP-1 Injury Defendants named in GLP-1 injury lawsuits have included manufacturers, sellers and/or distributors of various GLP-1 receptor agonist medications, including: Novo Nordisk (Ozempic, Rybelsus, Wegovy, Saxenda) Eli Lilly (Mounjaro, Zepbound, Trulicity) Other GLP-1 injury defendants Ozempic GLP-1 Lawsuit & Settlement Updates Recent updates about Ozempic lawsuits and settlements include: July 2026: GLP-1 lawsuits remain active in federal and state courts
GLP-1 agonists have transformed medical weight loss by targeting the biological mechanisms that make losing weight so difficult
Located in the United States
However, in states of leptin resistance such as obesity, this regulatory mechanism may be impaired ( 4.2 Central nervous system adaptations to taste in obesity Certain brain regions are responsible for processing sensory information through visual, olfactory, and auditory pathways, as well as gustatory signals
The agency hasnt been able to make a dent, she observed, as new websites continue to pop up
ArticlePubMedPMC 14
